FdaApplication
ANDA 206724
Identifiers
- fda_app_no: ANDA206724
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2016-11-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUDESONIDE | BUDESONIDE | 3MG | CAPSULE, DELAYED RELEASE;ORAL |
1 product